Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID.

Pub Date : 2024-01-01 DOI:10.3177/jnsv.70.174
Jelena Slankamenac, Marijana Ranisavljev, Nikola Todorovic, Jelena Ostojic, Valdemar Stajer, Darren G Candow, Laszlo Ratgeber, Jozsef Betlehem, Pongrac Acs, Sergej M Ostojic
{"title":"Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID.","authors":"Jelena Slankamenac, Marijana Ranisavljev, Nikola Todorovic, Jelena Ostojic, Valdemar Stajer, Darren G Candow, Laszlo Ratgeber, Jozsef Betlehem, Pongrac Acs, Sergej M Ostojic","doi":"10.3177/jnsv.70.174","DOIUrl":null,"url":null,"abstract":"<p><p>Preliminary studies demonstrated beneficial effects of dietary creatine across different post-viral fatigue syndromes. Creatine is often co-administered with glucose to improve its potency yet whether glucose boost the efficacy of creatine in long COVID remains currently unknown. In this report, we investigate the effects of 8-wk creatine intake with and without glucose on patient-reported outcomes, exercise tolerance, and tissue creatine levels in patients with long COVID. Fifteen male and female long COVID adult patients (age 39.7±16.0 y; 9 women) with moderate fatigue and at least one of additional long COVID-related symptoms volunteered to participate in this randomized controlled parallel-group interventional trial. All patients were allocated in a double-blind parallel-group design (1 : 1 : 1) to receive creatine (8 g of creatine monohydrate per day), a mixture of creatine and glucose (8 g of creatine monohydrate and 3 g of glucose per day), or placebo (3 g of glucose per day) t.i.d. during an 8-wk intervention interval. Two-way ANOVA with repeated measures (treatment vs. time interaction) revealed significant differences in changes in total creatine levels between the groups, showing an interaction effect at two brain locations (right precentral white matter F=34.740, p=0.008; partial η<sup>2</sup>=0.72; left paracentral grey matter F=19.243, p=0.019; partial η<sup>2</sup>=0.88), with creatine and creatine-glucose outcompeted placebo to elevate creatine levels at these two locations. Several long COVID symptoms (including body aches, breathing problems, difficulties concentrating, headache, and general malaise) were significantly reduced in creatine-glucose group at 8-wk follow-up (p≤0.05); the effect sizes for reducing body aches, difficulties concentrating, and headache were 1.33, 0.80, and 1.12, respectively, suggesting a large effect of creatine-glucose mixture for these outcomes. Our preliminary findings suggest that supplying exogenous creatine with glucose could be recommended as an effective procedure in replenishing brain creatine pool and alleviating long COVID features in this prevalent condition.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3177/jnsv.70.174","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Preliminary studies demonstrated beneficial effects of dietary creatine across different post-viral fatigue syndromes. Creatine is often co-administered with glucose to improve its potency yet whether glucose boost the efficacy of creatine in long COVID remains currently unknown. In this report, we investigate the effects of 8-wk creatine intake with and without glucose on patient-reported outcomes, exercise tolerance, and tissue creatine levels in patients with long COVID. Fifteen male and female long COVID adult patients (age 39.7±16.0 y; 9 women) with moderate fatigue and at least one of additional long COVID-related symptoms volunteered to participate in this randomized controlled parallel-group interventional trial. All patients were allocated in a double-blind parallel-group design (1 : 1 : 1) to receive creatine (8 g of creatine monohydrate per day), a mixture of creatine and glucose (8 g of creatine monohydrate and 3 g of glucose per day), or placebo (3 g of glucose per day) t.i.d. during an 8-wk intervention interval. Two-way ANOVA with repeated measures (treatment vs. time interaction) revealed significant differences in changes in total creatine levels between the groups, showing an interaction effect at two brain locations (right precentral white matter F=34.740, p=0.008; partial η2=0.72; left paracentral grey matter F=19.243, p=0.019; partial η2=0.88), with creatine and creatine-glucose outcompeted placebo to elevate creatine levels at these two locations. Several long COVID symptoms (including body aches, breathing problems, difficulties concentrating, headache, and general malaise) were significantly reduced in creatine-glucose group at 8-wk follow-up (p≤0.05); the effect sizes for reducing body aches, difficulties concentrating, and headache were 1.33, 0.80, and 1.12, respectively, suggesting a large effect of creatine-glucose mixture for these outcomes. Our preliminary findings suggest that supplying exogenous creatine with glucose could be recommended as an effective procedure in replenishing brain creatine pool and alleviating long COVID features in this prevalent condition.

分享
查看原文
为期八周的肌酸-葡萄糖补充剂可缓解长期 COVID 的临床特征。
初步研究表明,膳食中的肌酸对不同的病毒后疲劳综合征均有益处。肌酸通常与葡萄糖同时服用以提高其效力,但葡萄糖是否能提高肌酸在长期 COVID 中的疗效目前仍是未知数。在本报告中,我们研究了长期 COVID 患者在摄入 8 周肌酸的同时摄入或不摄入葡萄糖对患者报告结果、运动耐量和组织肌酸水平的影响。15名男性和女性长COVID成年患者(年龄为39.7±16.0岁;9名女性)自愿参加了这项随机对照平行组干预试验。所有患者均采用双盲平行组设计(1 : 1 : 1),在为期 8 周的干预间隔期内,分别接受肌酸(每天 8 克一水肌酸)、肌酸和葡萄糖混合物(每天 8 克一水肌酸和 3 克葡萄糖)或安慰剂(每天 3 克葡萄糖)治疗。重复测量的双向方差分析(治疗与时间的交互作用)显示,各组间肌酸总水平的变化存在显著差异,并在两个脑部位置显示出交互作用效应(右侧前中央白质 F=34.740,p=0.008;部分η2=0.72;左侧中央灰质旁 F=19.243,p=0.019;部分η2=0.88),肌酸和肌酸葡萄糖在这两个位置的肌酸水平升高方面优于安慰剂。在 8 周的随访中,肌酸葡萄糖组的几种长期 COVID 症状(包括身体疼痛、呼吸困难、注意力难以集中、头痛和全身不适)明显减轻(P≤0.05);减轻身体疼痛、注意力难以集中和头痛的效应大小分别为 1.33、0.80 和 1.12,表明肌酸葡萄糖混合物对这些结果有很大的影响。我们的初步研究结果表明,在葡萄糖中加入外源性肌酸可作为补充脑肌酸库的有效方法,并可减轻这一流行病的长期 COVID 特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信